FDA Is Considering Adding A Warning About Risk Of A Rare Heart Inflammation That Can Be Caused By BioNTech (BNTX), Moderna (MRNA) COVID-19 Vaccines

The U.S. Food and Drug Administration recently stated on its agenda is its plan to work quickly to add a warning to the fact sheet for the BioNTech SE – ADR (NASDAQ: BNTX) and Moderna (NASDAQ: MRNA) COVID-19 vaccines about the rare possible cases of heart inflammation that can be caused in adolescents and young adults. 

Advantages of BioNTech SE – ADR and Moderna vaccines greater than the risks

In a recent meeting of U.S. Centers for Disease Control and Prevention (CDC) advisory groups, reported cases of the heart condition post-vaccination, brought to light that inflammation in adolescents and young adults could be linked to the vaccines. Concurrently, the advantages of the vaccines are more than the risk they can cause. The CDC also stated that it had taken note that patients with heart inflammation post getting inoculated recover from the symptoms and get back to their routine. 

Simultaneously, in a statement, the U.S. Department of Health And Human Services retreated that vaccines are safe, effective and termed that the heart condition linked to the vaccines is extremely rare. 

This news impacted the share value of both companies. While BioNTech SE – ADR shares fell 1.4%, Moderna Inc shares closed down 4.2%. 

In a BioNTech SE – ADR statement, the company clarified that it is aware of reports of possible myocarditis and pericarditis post the mRNA vaccination. The statement added that the benefit-risk profile of the BioNTech SE – ADR vaccine remains positive. The vaccine manufactured by the company has received a go-ahead from the American government to be administered to Americans who are as young as 12 years old. 

Moderna Inc is aware of cases of heart inflammation post-vaccination  

A source from Moderna Inc stated that the company is aware of reports of the cases of heart inflammation caused after having the mRNA vaccine administered. The source added that the company is working closely with the concerned authorities in this regard. 

In the backdrop of the respective reports surfacing in the media, health officials and medical professionals in several parts of the globe are investigating if the vaccines from the two companies which use the latest mRNA technology are a risk. If they are, medical experts are working towards learning about the seriousness of the risk.

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. We may be compensated for posting this content on our website by EDM Media LLC. For questions, comments or suggestions please contact ir@edm.media.

Published by Pamela Garcia

Pamela Garcia is a keen follower of U.S. stock market

Recent Stories

SignUp Now For Our Featured Newsletter